Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric Disease

To assess the clinical value of dual time point imaging (DTPI) fluorine-18fludeoxyglucose (18F-FDG) positron emission tomography (PET)/CT in differentiating malignancy and benign disease of patients with focally increased gastric uptake. Patients who present focally increased 18F-FDG uptake in gastr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Jing, Zhao, Panxiong, Ren, Zhentai, Liu, Baoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616455/
https://www.ncbi.nlm.nih.gov/pubmed/26287421
http://dx.doi.org/10.1097/MD.0000000000001356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616455/
https://www.ncbi.nlm.nih.gov/pubmed/26287421
http://dx.doi.org/10.1097/MD.0000000000001356

Ejemplares similares